210 related articles for article (PubMed ID: 36369198)
1. WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System.
Zhao Z; Zhang KN; Sun Z; Yang C; Wang Q; Li G; Wang Z; Zeng F; Chai R; Qian Z; Wang Z; Liu Y; Ma W; Wu F; Jiang T
Sci Data; 2022 Nov; 9(1):692. PubMed ID: 36369198
[TBL] [Abstract][Full Text] [Related]
2. Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors.
Ramkissoon SH; Fernandes H; Lopez-Terrada DH; Hameed MR; Trembath DG; Bridge JA; Lindeman NI; Souers RJ; Vasalos P; Brat DJ; Moncur JT
Arch Pathol Lab Med; 2022 May; 147(5):518-524. PubMed ID: 35878398
[TBL] [Abstract][Full Text] [Related]
3. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
Wood MD; Halfpenny AM; Moore SR
Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
[TBL] [Abstract][Full Text] [Related]
4. Classification of adult-type diffuse gliomas: Impact of the World Health Organization 2021 update.
Whitfield BT; Huse JT
Brain Pathol; 2022 Jul; 32(4):e13062. PubMed ID: 35289001
[TBL] [Abstract][Full Text] [Related]
5. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC
Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas.
Zhao Z; Meng F; Wang W; Wang Z; Zhang C; Jiang T
Sci Data; 2017 Mar; 4():170024. PubMed ID: 28291232
[TBL] [Abstract][Full Text] [Related]
7. The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021.
Perez A; Huse JT
Curr Neurol Neurosci Rep; 2021 Nov; 21(12):67. PubMed ID: 34817712
[TBL] [Abstract][Full Text] [Related]
8. Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.
Onizuka H; Masui K; Komori T
Int J Clin Oncol; 2020 Jun; 25(6):997-1003. PubMed ID: 32468200
[TBL] [Abstract][Full Text] [Related]
9. Major Features of the 2021 WHO Classification of CNS Tumors.
Smith HL; Wadhwani N; Horbinski C
Neurotherapeutics; 2022 Oct; 19(6):1691-1704. PubMed ID: 35578106
[TBL] [Abstract][Full Text] [Related]
10. [Pay attention to molecular pathological diagnosis of pediatric glioma].
Teng LH; Lu DH
Zhonghua Yi Xue Za Zhi; 2022 May; 102(19):1411-1416. PubMed ID: 35599404
[TBL] [Abstract][Full Text] [Related]
11. WHO CNS5 2021 classification of gliomas: a practical review and road signs for diagnosing pathologists and proper patho-clinical and neuro-oncological cooperation.
Sejda A; Grajkowska W; Trubicka J; Szutowicz E; Wojdacz T; Kloc W; Iżycka-Świeszewska E
Folia Neuropathol; 2022; 60(2):137-152. PubMed ID: 35950467
[TBL] [Abstract][Full Text] [Related]
12. WHO 2016 Classification of gliomas.
Wesseling P; Capper D
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):139-150. PubMed ID: 28815663
[TBL] [Abstract][Full Text] [Related]
13. Update of the 2021 WHO classification of tumors of the central nervous system: adult diffuse gliomas.
Komori T
Brain Tumor Pathol; 2023 Jan; 40(1):1-3. PubMed ID: 36538117
[No Abstract] [Full Text] [Related]
14. The molecular framework of pediatric-type diffuse gliomas: shifting toward the revision of the WHO classification of tumors of the central nervous system.
Komori T
Brain Tumor Pathol; 2021 Jan; 38(1):1-3. PubMed ID: 33398472
[No Abstract] [Full Text] [Related]
15. Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems.
Sonoda Y
Int J Clin Oncol; 2020 Jun; 25(6):1004-1009. PubMed ID: 32020379
[TBL] [Abstract][Full Text] [Related]
16. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
Bale TA; Rosenblum MK
Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
[TBL] [Abstract][Full Text] [Related]
17. [The introduction of pediatric-type diffuse low-grade gliomas in 2021 WHO classification of tumors of the central nervous system (5th edition)].
Du ZG; Wang Y; Xiong J
Zhonghua Bing Li Xue Za Zhi; 2022 Nov; 51(11):1090-1093. PubMed ID: 36323536
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
Gritsch S; Batchelor TT; Gonzalez Castro LN
Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681
[TBL] [Abstract][Full Text] [Related]
19. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.
Weller M; van den Bent M; Preusser M; Le Rhun E; Tonn JC; Minniti G; Bendszus M; Balana C; Chinot O; Dirven L; French P; Hegi ME; Jakola AS; Platten M; Roth P; Rudà R; Short S; Smits M; Taphoorn MJB; von Deimling A; Westphal M; Soffietti R; Reifenberger G; Wick W
Nat Rev Clin Oncol; 2021 Mar; 18(3):170-186. PubMed ID: 33293629
[TBL] [Abstract][Full Text] [Related]
20. Imaging of Central Nervous System Tumors Based on the 2016 World Health Organization Classification.
Ly KI; Wen PY; Huang RY
Neurol Clin; 2020 Feb; 38(1):95-113. PubMed ID: 31761063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
